Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents

  1. Amaral, A.T.
  2. Garofalo, C.
  3. Frapolli, R.
  4. Manara, M.C.
  5. Mancarella, C.
  6. Uboldi, S.
  7. Di Giandomenico, S.
  8. Ordóñez, J.L.
  9. Sevillano, V.
  10. Malaguarnera, R.
  11. Picci, P.
  12. Hassan, A.B.
  13. De Alava, E.
  14. D'Incalci, M.
  15. Scotlandi, K.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Argitalpen urtea: 2015

Alea: 21

Zenbakia: 6

Orrialdeak: 1373-1382

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-14-1688 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus